Showing results (51-60 of 421) with videos related to
Sort By:
Pageof 43
Blood|September 15, 1992
Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidineW J Murphy, G Tsarfaty, D L LongoThe Journal of Biological Chemistry|April 4, 1997
Cell cycle regulation of the human polo-like kinase (PLK) promoterT Uchiumi, D L Longo, D K FerrisCancer|April 15, 1995
A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancerD W Fennelly, L Norton, M Sznol, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1987
Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphomaS H Bridges, A M Kruisbeek, D L LongoCritical Reviews in Oncology/Hematology|January 1, 1986
Nodular lymphomas: current conceptsL A Matis, R C Young, D L LongoThe American Journal of Surgical Pathology|February 1, 1992
CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of diseaseJ T Sundeen, D L Longo, E S JaffeJournal of the National Cancer Institute. Monographs|January 1, 1990
Treatment of patients with aggressive lymphomas: an overviewW J Urba, P L Duffey, D L LongoProceedings of the National Academy of Sciences of the United States of America|May 15, 1992
Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient miceW J Murphy, S K Durum, D L LongoThe Journal of Experimental Medicine|May 1, 1989
Preferential differentiation of T cell receptor specificities based on the MHC glycoproteins encountered during development. Evidence for positive selectionS Marusić-Galesić, D L Longo, A M KruisbeekScience (New York, N.Y.)|July 3, 1987
T-cell tumor elimination as a result of T-cell receptor-mediated activationJ D Ashwell, D L Longo, S H BridgesPageof 43